The latest automated docking technologies for novel drug discovery

被引:29
|
作者
Caballero, Julio [1 ]
机构
[1] Univ Talca, Fac Ingn, Dept Bioinformat, Ctr Bioinformat Simulac & Modelado CBSM, Talca, Chile
关键词
Flexible docking; reverse docking; covalent docking; scoring function; structure-based virtual screening; qm-based docking; ensemble docking; FLEXIBLE-RECEPTOR DOCKING; SCORING FUNCTIONS; COVALENT DOCKING; INDUCED FIT; WEB SERVER; PROTEIN FLEXIBILITY; ENERGY ESTIMATION; ACCURATE DOCKING; REVERSE DOCKING; BINDING MODES;
D O I
10.1080/17460441.2021.1858793
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction Molecular docking has been consolidated as one of the most important methods in the molecular modeling field. It has been recognized as a prominent tool in the study of protein-ligand complexes, to describe intermolecular interactions, to accurately predict poses of multiple ligands, to discover novel promising bioactive compounds. Molecular docking methods have evolved in terms of their accuracy and reliability; but there are pending issues to solve for improving the connection between the docking results and the experimental evidence Areas covered In this article, the author reviews very recent innovative molecular docking applications with special emphasis on reverse docking, treatment of protein flexibility, the use of experimental data to guide the selection of docking poses, the application of Quantum mechanics(QM) in docking, and covalent docking. Expert opinion There are several issues being worked on in recent years that will lead to important breakthroughs in molecular docking methods in the near future These developments are related to more efficient exploration of large datasets and receptor conformations, advances in electronic description, and the use of structural information for guiding the selection of results.
引用
收藏
页码:625 / 645
页数:21
相关论文
共 50 条
  • [21] Acceleration of high-throughput molecular docking for novel drug discovery on supercomputers
    Ellingson, Sally R.
    Smith, Jeremy C.
    Baudry, Jerome
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [22] Automated docking receptor selection workflow for non-nucleoside reverse transcriptase drug discovery
    Stanton, Richard A.
    Brown, Kyle A.
    Uppal, Karan
    Gernert, Kim M.
    Nettles, James H.
    Schinazi, Raymond F.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [23] Microfluidic technologies in drug discovery
    Pihl, J
    Karlsson, M
    Chiu, DT
    [J]. DRUG DISCOVERY TODAY, 2005, 10 (20) : 1377 - 1383
  • [24] Technologies for transporter drug discovery
    Weinglass, Adam B.
    Garcia, Maria L.
    Kaczorowski, Gregory L.
    [J]. CHANNELS, 2008, 2 (05) : 312 - 321
  • [25] Microdispensing technologies in drug discovery
    Rose, D
    [J]. DRUG DISCOVERY TODAY, 1999, 4 (09) : 411 - 419
  • [26] Latest advances in aging research and drug discovery
    Bakula, Daniela
    Ablasser, Andrea
    Aguzzi, Adriano
    Antebi, Adam
    Barzilai, Nir
    Bittner, Martin-Immanuel
    Jensen, Martin Borch
    Calkhoven, Cornelis F.
    Chen, Danica
    de Grey, Aubrey D. N. J.
    Feige, Jerome N.
    Georgievskaya, Anastasia
    Gladyshev, Vadim N.
    Golato, Tyler
    Gudkov, Andrei V.
    Hoppe, Thorsten
    Kaeberlein, Matt
    Katajisto, Pekka
    Kennedy, Brian K.
    Lal, Unmesh
    Martin-Villalba, Ana
    Moskalev, Alexey A.
    Ozerov, Ivan
    Petr, Michael A.
    Reason
    Rubinsztein, David C.
    Tyshkovskiy, Alexander
    Vanhaelen, Quentin
    Zhavoronkov, Alex
    Scheibye-Knudsen, Morten
    [J]. AGING-US, 2019, 11 (22): : 9971 - 9981
  • [27] Novel BD Gentest™ ADME-Tox technologies for drug discovery
    Miller, VP
    [J]. DRUG METABOLISM REVIEWS, 2004, 36 : 38 - 38
  • [28] Novel BD Gentest™ ADME-Tox technologies for drug discovery
    Miller, V
    [J]. DRUG METABOLISM REVIEWS, 2002, 34 : 31 - 31
  • [29] Novel BD Gentest™ ADME-tox technologies for drug discovery
    Miller, V
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 27 - 27
  • [30] Automated electrophysiology in drug discovery
    Priest, B. T.
    Swensen, A. M.
    McManus, O. B.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (23) : 2325 - 2337